Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Monsanto: Merger costs suppress margins - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Jan 22, 2001

    Monsanto: Merger costs suppress margins

    Monsanto has declared a net profit of Rs 89 m on a turnover of Rs 1.19 bn for the third quarter of the current year. Though the operating margins for the current quarter vis-à-vis the corresponding quarter have gone up substantially, the results are not strictly comparable.

    (Rs m) 3QFY00 3QFY01 9m FY00 9m FY01 Change FY00
    Sales 57 1,198 916 2,532 176.6% 1,132
    Other Income 3 7 5 22 363.8% 13
    Expenditure 56 1,080 787 2,271 188.7% 996
    Operating Profit (EBDIT) 1 117 129 261 102.8% 136
    Operating Profit Margin (%) 1.2% 9.8% 14.1% 10.3%   12.0%
    Interest (0) 7 20 20 2.6% 25
    Depreciation 2 16 6 40 539.7% 7
    Profit before Tax 2 101 108 223 106.8% 117
    Other Adjustments       27   3
    Tax - 13 3 13 333.3% -
    Profit after Tax/(Loss) 2 89 105 237 126.1% 120
    Net profit margin (%) 3.2% 7.4% 11.4% 9.3%   10.6%
    Earnings per share* 1.67 82.51 48.70 110.09   27.98

    This is because, till last year, the company had four entities operating in India. These were Monsanto Chemicals, the listed company which was a manufacturer of herbicides, Monsanto Enterprises a 100% subsidiary of the parent which was into the marketing these products, Monsanto Technologies (another wholly owned subsidiary of the parent) was engaged in the manufacture of seeds and finally, Monsanto Holdings, a third 100% subsidiary, which was holding the equity in Monsanto Chemicals!!

    Last year, the company merged the three unlisted companies into the listed company. Hence the current quarter’s numbers include the figures of the other three companies as well. Hence it would be relatively meaningful if one were to look at the operating margins of the full nine months in the current year and compare those with the comparable figures for the nine months of last year. These have actually dropped from 14% last year to 10% in the current year.

    The management has explained that the staff cost, depreciation and other expenses have increased as compared to the previous periods due to the acquisition of agriculture business of Monsanto Enterprises and agriculture business related assets of Monsanto Holdings.

    The stock has come off from its yearly high (recorded pre–merger) of Rs 1,955 to the current level of Rs 1,026. The current valuations imply an earnings multiple of 12.4 times. However, if one were to overlook these short term concerns and focus on the fact that internationally, the company is one of the pioneers in the biotech business and the fact that the interests of both the majority and minority shareholders are more closely aligned now, long term investors could take a relook at the stock at its current valuations.



    Equitymaster requests your view! Post a comment on "Monsanto: Merger costs suppress margins". Click here!


    More Views on News

    Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

    Aug 14, 2017

    A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

    Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

    Aug 14, 2017

    GST impact coupled with price erosion in US leads to lower profits for the quarter.

    Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

    Aug 8, 2017

    Profits plunge due to higher raw material costs.

    Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

    Jun 23, 2017

    Net Profit lower due to exceptional items in the previous year.

    Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

    May 30, 2017

    US markets decline while other geographies grow in the quarter.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 23, 2017 03:36 PM


    • Track your investment in MONSANTO INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks



    Detailed Financial Information With Charts